Question

How would you describe a monument to
tourists ? Do you require any preparation for
this ? Write a brief commentary on any one
monument of your choice.

31 May 2018
Answer :
Word Count : 498

Sure, let's dive into the fascinating world of monuments and tourism development!

A monument, in the context of tourism, can be seen as a symbol of cultural, historical, or artistic significance that attracts visitors. It's not just a structure; it's a living testament to the past, a piece of heritage that tells a story. When describing a monument to tourists, it's important to blend historical context with an engaging narrative to captivate their interest.

Preparation is key in delivering a memorable experience to tourists. It goes beyond just knowing the historical facts; it involves understanding the cultural nuances, appreciating the architectural details, and being aware of the monument's role in shaping the local identity. A guide should be well-versed in the broader historical and cultural context, enabling them to answer questions and offer insights beyond the surface level.

Now, let's delve into a specific monument: the iconic Taj Mahal

_______ ____ ___ __________ ____ ______ ______.
___ _________ ____ __________ __________.
______ ________ _____ ____ ______ __________ ____ ___ ___.
______ _______ _________ _____ ___ ______ ____ ______ ____ _____ ____.
_______ ___ ________ __________ _______ _________ _________ __________ ________ _________.
______ ______ _________ ____ ________ ______ _________ ______ _______ ____ ________.
_________ ________ ______ __________ _____.
_______ _______ _____ ____ ____ ________ ___ ________ _______ _______ ____.
______ _________ _____ ____ ___ __________.
_______ ________ ____ ____ _____ __________ ________ ______ ____ _______.
_____ ___ ____ _____ ________ ________ _________ _________ __________ __________.
____ ________ ____ _________ ________ ___ ________ _____ _______ _________.
__________ ___ _________ ______ _________ ____ ________ _____ _______.
____ ________ ________ ___ _____ ______.
____ _________ ________ ________ ________ _____ ________ _______ _______.
___ ______ _________ ____ ___.
_________ _____ __________ __________ ______ _______ __________ __________ ____ _____.
__________ ___ _________ ____ ____ ______ _________ _________ ________ ______.
_____ __________ ________ ___ ______ _____ __________ ________ ________ ________ ____.
________ ______ __________ _____ __________ ___.
_____ _______ ______ ____ ____ ____ ________ __________ __________ ________ _______ ___.
_____ _____ _____ ____ ___ _________ __________ _______.
______ ________ _______ ______ _______ _______ ________ ___ _____ ________ ______ _____.
__________ _________ ________ _____ _________ __________ ____ ________ ________.
___ ________ ________ ___ _________ ________ ______ ______ _____ ___.
__________ _______ _______ _______ ___ _______.
___ __________ ________ ______ ______ ________ _____ ________.
___ ____ _____ __________ ______ ______ _____ _______ ________ _________ _____ ____.
_______ _________ _____ ____ _____ ___ ______ ________ __________ ___ _________ ______.
_______ ___ ____ _______ __________ ______.
_______ __________ ______ _______ __________ ____.
________ _______ ___ ___ _____.
__________ _________ _________ __________ __________.
______ _____ ______ ___ _______ ____ ______.
_______ ______ _______ ___ _____ ______ _____ ___ ____ ______ _____ __________.
____ ______ _____ ___ __________ _______ ______ _______ _____ ___ ____.
______ ____ ____ ____ __________ _________.
_________ ________ ___ ________ _______ _______ ________ ________.
___ __________ __________ _____ _______ __________ ________ ___ _________.
_________ ______ ______ ______ ________.
__________ _______ ________ ____ ___ _____ _____ __________ ___.
IGNOU ACADEMY
Your IGNOU journey, made easier.
  • Solved Assignments
  • Study Notes
  • Guess Papers
  • Question Papers
Call Us WhatsApp
STUDY • PREPARE • SUCCEED
Skip in 10
Related Questions
    Due for submission on 5th of following Month  
  Month
Year		  
   
   
 
   
   
  Numbers reported during the month Ref.No
Part A REPRODUCTIVE AND CHILD HEALTH
M1 Ante Natal Care (ANC) M1
1.1 Total number of pregnant women registered for ANC     1.1
1.1.1 Out of the total ANC registered, number registered within 1st trimester (within 12 weeks)     1.1.1
1.2 ANC services   1.2
1.2.1 Number of PW given TT1     1.2.1
1.2.2 Number of PW given TT2     1.2.2
1.2.3 Number of PW given TT Booster     1.2.3
1.2.4 Number of PW given 180 Iron Folic Acid (IFA) tablets     1.2.4
1.2.5 Number of PW given 360 Calcium tablets     1.2.5
1.2.6 Number of PW given one Albendazole tablet after 1st trimester     1.2.6
1.2.7 Number of PW received 4 or more ANC check ups     1.2.7
1.2.8 Number of PW given ANC Corticosteroids in Pre Term Labour     1.2.8
1.3 Pregnant women (PW) with Hypertension (BP>140/90)   1.3
1.3.1 New cases of PW with hypertension detected     1.3.1
1.3.1.a Out of the new cases of PW with hypertension detected, cases managed at institution     1.3.1.a
1.3.2 Number of Eclampsia cases managed during delivery     1.3.2
1.4 Pregnant women (PW) with Anaemia   1.4
1.4.1 Number of PW tested for Haemoglobin (Hb ) 4 or more than 4 times for respective ANCs     1.4.1
1.4.2 Number of PW having Hb level<11 (tested cases)(7.1 to 10.9)     1.4.2
1.4.3 Number of PW having Hb level<7 (tested cases)     1.4.3
1.4.4 Number of PW having severe anaemia (Hb<7) treated     1.4.4
1.5 Pregnant women (PW) with Gestational Diabetes Mellitus (GDM)   1.5
1.5.1 Number of PW tested for blood sugar using OGTT (Oral Glucose Tolerance Test)     1.5.1
1.5.2 Number of PW tested positive for GDM     1.5.2
1.5.3 Number of PW given insulin out of total tested positive for GDM     1.5.3
1.6 Pregnant Women (PW) with Syphilis   1.6
1.6.1 Syphilis test conducted for Pregnant Women   1.6.2
1.6.1.a Number of pregnant women tested for Syphilis     1.6.2.a
1.6.1.b Number of pregnant women tested found sero positive for Syphilis     1.6.2.b
1.6.1.c Number of syphilis positive pregnant women treated for Syphilis     1.6.2.c
1.6.1.d Number of babies diagnosed with Congenital Syphilis     1.6.2.d
1.6.1.e Number of babies treated for congenital Syphilis     1.6.2.e
M2 Deliveries   M2
2.1 Deliveries conducted at Home   2.1
2.1.1 Number of Home Deliveries attended by   2.1.1
2.1.1.a Number of Home Deliveries attended by Skill Birth Attendant(SBA) (Doctor/Nurse/ANM)     2.1.1.a
2.1.1.b Number of Home Deliveries attended by Non SBA (Trained Birth Attendant(TBA) /Relatives/etc.)     2.1.1.b
2.1.2 Number of PW given Tablet Misoprostol during home delivery     2.1.2
2.1.3 Number of newborns received 7 Home Based Newborn Care (HBNC) visits in case of Home delivery     2.1.3
2.2 Number of Institutional Deliveries conducted (Including C-Sections)     2.2
2.2.1 Out of total institutional deliveries number of women discharged within 48 hours of delivery     2.2.1
2.2.2 Number of newborns received 6 HBNC visits after Institutional Delivery     2.2.2
M3 Number of Caesarean (C-Section) deliveries   M3
3.1 Total C -Section deliveries performed     3.1
3.1.1 C-sections, performed at night (8 PM- 8 AM)     3.1.1
M4 Pregnancy outcome & details of new-born   M4
4.1 Pregnancy Outcome (in number)   4.1
4.1.1 Live Birth   4.1.1
4.1.1.a Live Birth - Male     4.1.1.a
4.1.1.b Live Birth - Female     4.1.1.b
4.1.2 Number of Pre term newborns ( < 37 weeks of pregnancy)     4.1.2
4.1.3 Still Birth     4.1.3
4.2 Abortion (spontaneous)     4.2
4.3 Medical Termination of Pregnancy (MTP)   4.3
4.3.1 Number of MTPs conducted   4.3.1
4.3.1.a MTP up to 12 weeks of pregnancy     4.3.1.a
4.3.1.b MTP more than 12 weeks of pregnancy     4.3.1.b
4.3.2 Post Abortion/ MTP Complications   4.3.2
4.3.2.a Post Abortion/ MTP Complications Identified     4.3.2.a
4.3.2.b Post Abortion/ MTP Complications Treated     4.3.2.b
4.3.3 Number of women provided with post abortion/ MTP contraception     4.3.3
4.4 Details of Newborn children   4.4
4.4.1 Number of newborns weighed at birth     4.4.1
4.4.2 Number of newborns having weight less than 2.5 kg     4.4.2
4.4.3 Number of Newborns breast fed within 1 hour of birth     4.4.3
M5 Complicated Pregnancies   M5
5.1 Number of cases of pregnant women with Obstetric Complications attended (Antepartum haemorrhage (APH), Post-Partum Hemorrhage (PPH), Sepsis, Eclampsia and others)     5.1
M6 Post Natal Care (PNC)   M6
6.1 Women receiving 1st post partum checkup within 48 hours of home delivery     6.1
6.2 Women receiving 1st post partum checkup between 48 hours and 14 days     6.2
6.3 Number of mothers provided full course of 180 IFA tablets after delivery     6.3
6.4 Number of mothers provided 360 Calcium tablets after delivery     6.4
M7 Reproductive Tract Infections/Sexually Transmitted Infections (RTI/STI) Cases   M7
7.1 Number of new RTI/STI cases identified   7.1
7.1.1 New RTI/STI cases identified - Male     7.1.1
7.1.2 New RTI/STI cases identified - Female     7.1.2
7.2 Number of new RTI/STI for which treatment initiated   7.2
7.2.1 RTI/STI for which treatment initiated - Male     7.2.1
7.2.2 RTI/STI for which treatment initiated -Female     7.2.2
M8 Family Planning   M8
8.1 MALE STERLISATION   8.1
8.1.1 Number of Non Scalpel Vasectomy (NSV) / Conventional Vasectomy conducted     8.1.1
8.2 FEMALE STERLISATION   8.2
8.2.1 Number of Laparoscopic sterilizations (excluding post abortion) conducted     8.2.1
8.2.2 Number of Interval Mini-lap (other than post-partum and post abortion) sterilizations conducted     8.2.2
8.2.3 Number of Postpartum sterilizations (within 7 days of delivery by minilap or concurrent with caesarean section) conducted     8.2.3
8.2.4 Number of Post Abortion sterilizations (within 7 days of spontaneous or surgical abortion) conducted     8.2.4
8.3 Number of Interval IUCD Insertions (excluding PPIUCD and PAIUCD)     8.3
8.4 Number of Postpartum (within 48 hours of delivery) IUCD insertions     8.4
8.5 Number of Post Abortion (within 12 days of spontaneous or surgical abortion) IUCD insertions     8.5
8.6 Number of IUCD Removals     8.6
8.7 Number of complications following IUCD Insertion     8.7
8.8 Injectable Contraceptive-Antara Program- First Dose     8.8
8.9 Injectable Contraceptive-Antara Program- Second Dose     8.9
8.1 Injectable Contraceptive-Antara Program- Third Dose     8.1
8.11 Injectable Contraceptive-Antara Program- Fourth or more than fourth     8.11
8.12 Number of Combined Oral Pill cycles distributed     8.12
8.13 Number of Condom pieces distributed     8.13
8.14 Number of Centchroman (weekly) pills strips distributed     8.14
8.15 Number of Emergency Contraceptive Pills (ECP) given     8.15
8.16 Number of Pregnancy Test Kits (PTK) used     8.16
8.17 Quality in sterilization services   8.17
8.17.1 Complications following male sterilization     8.17.1
8.17.2 Complications following female sterilization     8.17.2
8.17.3 Failures following male sterilization     8.17.3
8.17.4 Failures following female sterilization     8.17.4
8.17.5 Deaths following male sterilization     8.17.5
8.17.6 Deaths following female sterilization     8.17.6
M9 CHILD IMMUNISATION   M9
9.1 Number of Infants 0 to 11 months old who received:   9.1
9.1.1 Child immunisation - Vitamin K1 (Birth Dose)     9.1.1
9.1.2 Child immunisation - BCG     9.1.2
9.1.3 Child immunisation - DPT1     9.1.3
9.1.4 Child immunisation - DPT2     9.1.4
9.1.5 Child immunisation - DPT3     9.1.5
9.1.6 Child immunisation - Pentavalent 1     9.1.6
9.1.7 Child immunisation - Pentavalent 2     9.1.7
9.1.8 Child immunisation - Pentavalent 3     9.1.8
9.1.9 Child immunisation - OPV 0 (Birth Dose)     9.1.9
9.1.10 Child immunisation - OPV1     9.1.10
9.1.11 Child immunisation - OPV2     9.1.11
9.1.12 Child immunisation - OPV3     9.1.12
9.1.13 Child immunisation - Hepatitis-B0 (Birth Dose)     9.1.13
9.1.14 Child immunisation - Hepatitis-B1     9.1.14
9.1.15 Child immunisation - Hepatitis-B2     9.1.15
9.1.16 Child immunisation - Hepatitis-B3     9.1.16
9.1.17 Child immunisation - Inactivated Polio Vaccine 1 (IPV 1)     9.1.17
9.1.18 Child immunisation - Inactivated Polio Vaccine 2 (IPV 2)     9.1.18
9.1.19 Child immunisation - Rotavirus 1     9.1.19
9.1.20 Child immunisation - Rotavirus 2     9.1.20
9.1.21 Child immunisation - Rotavirus 3     9.1.21
9.2 Number of Children 9-11 months who received:   9.2
9.2.1 Child immunisation (9-11months) - Measles & Rubella (MR)- 1st Dose     9.2.1
9.2.2 Child immunisation (9-11months) - Measles 1st dose     9.2.2
9.2.3 Child immunisation (9-11months) - JE 1st dose     9.2.3
9.2.4 Number of children aged between 9 and 11 months fully immunized (BCG+DPT123/ pentavalent123+OPV123+Measles/ MR)   9.2.4
9.2.4.a Chi

What do you mean by the term "tour package" ?
Discuss in detail various destinations covered by
Palace on Wheels

Pilgrimage Tourism

Examine the tourist traffic trends from Europe. Discuss some of the major
characteristics of the European tourist market

Write an essay on 'Palace on Wheels

Guest-host relationship

The Hermit City : Ladakh
IGNOU Solved Assignments Assignments Ignou Projects Project Previous Year Solved Exam Papers Notes Notes Sample Question Papers Sample Question Papers
Login
Top